Professur für Translationale Immunologie

The role of glucose transporter type 1 in plasma cells (2021) Bierling T, Gumann A, Van Schie K, Wichert M, Hauke M, Wittner J, Schuh W, et al. Conference contribution SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination (2021) Hoffmann M, Hofmann-Winkler H, Krüger N, Kempf A, Nehlmeier I, Graichen L, Arora P, et al. Journal article Complement Activation in Kidneys of Patients With COVID-19 (2021) Pfister F, Vonbrunn E, Ries T, Jäck HM, Überla K, Lochnit G, Sheriff A, et al. Journal article Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) Cossarizza A, Chang HD, Radbruch A, Abrignani S, Addo R, Akdis M, Andrä I, et al. Journal article Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability (2021) Burnett DL, Jackson KJ, Langley DB, Aggrawal A, Stella AO, Johansen MD, Balachandran H, et al. Journal article The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency (2021) Arora P, Rocha C, Kempf A, Nehlmeier I, Graichen L, Winkler MS, Lier M, et al. Journal article Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance (2021) Arora P, Kempf A, Nehlmeier I, Graichen L, Sidarovich A, Winkler MS, Schulz S, et al. Journal article A surrogate cell-based SARS-CoV-2 spike blocking assay (2021) Schuh W, Baus L, Steinmetz T, Schulz S, Weckwerth L, Roth E, Hauke M, et al. Journal article SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies (2021) Hoffmann M, Arora P, Groß R, Seidel A, Hörnich BF, Hahn AS, Krüger N, et al. Journal article SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization (2021) Hoffmann M, Zhang L, Krüger N, Graichen L, Kleine-Weber H, Hofmann-Winkler H, Kempf A, et al. Journal article